Neurocrine Biosciences NBIX Q1 2026 Earnings EPS Smashes Estimates Stock Edges Higher AMRN Q1 2026 Earnings Significant EPS Miss Widens Uncertainty MDB Q1 2026 Earnings EPS Beats Estimates by 127 Stock Slips 35 PCVX Q1 2026 Earnings Wider Than Expected Loss as PreRevenue Biotech Advances Vaccine Pipeline TaskUs Inc TASK Q1 2026 Earnings Small EPS Miss on Modest Revenue Uncertainty DOCS Q1 2026 Earnings Mixed Results as EPS Misses Estimates but Stock Rises